Central α-melanocyte-stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits

Brain Research

Volumn 948, Issue 1-2, 2002, Pages 145-148

  Matsumura, Kiyoshi ^a   Tsuchihashi, Takuya ^a   Abe, Isao ^a   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Melanocyte stimulating hormone; Agouti related protein; Central nervous system; Melanocortin 4 receptor; Sympathetic nervous system

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; JKC 363; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BRAIN TISSUE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; KIDNEY; MALE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ALPHA-MSH; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CONSCIOUSNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROTEINS; RABBITS; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, CORTICOTROPIN; SYMPATHETIC NERVOUS SYSTEM;

EID: 0037032105     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03045-7     Document Type: Article

References (24)

1. Aizawa-Abe M., Ogawa Y., Masuzaki H., Ebihara K., Satoh N., Iwai H., Matsuoka N., Hayashi T., Hosoda K., Inoue G., Yoshimasa Y., Nakao K. Pathophysiological role of leptin in obesity-related hypertension. J. Clin. Invest. 105:2000;1243-1252.
2. Correia M.L.G., Haynes W.G., Rahmouni K., Morgan D.A., Sivitz W.I., Mark A.L. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes. 51:2002;439-442.
3. Dinulescu D.M., Cone R.D. Agouti and agouti-related protein: analogies and contrasts. J. Biol. Chem. 275:2000;6695-6698.
4. Dunbar J.C., Lu H. Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions. Peptides. 21:2000;211-217.
5. Elmquist J.K., Elias C.F., Saper C.B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron. 22:1999;221-232.
6. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
7. Giraudo S.Q., Billington C.J., Levine A.S. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands. Brain Res. 809:1998;302-306.
8. Grundy H.F. Cardiovascular effects of morphine, pethidine, diamorphine and nalorphine on the cat and rabbit. Br. J. Pharmacol. 42:1971;159-178.
9. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
10. Ishikawa N., Kallman C.H., Sagawa K. Rabbit carotid sinus reflex under pentobarbital, urethan, and chloralose anesthesia. Am. J. Physiol. 246:1984;H696-H701.
11. Kiefer L.L., Veal J.M., Mountjoy K.G., Wilkison W.O. Melanocortin receptor binding determinants in the agouti protein. Biochemistry. 37:1998;991-997.
12. Kim M.S., Small C.J., Russell S.H., Morgan D.G., Abbott C.R., al Ahmed S.H., Hay D.L., Ghatei M.A., Smith D.M., Bloom S.R. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors. J. Neuroendocrinol. 14:2002;276-282.
13. Lu D., Willard D., Patel I.R., Kadwell S., Overton L., Kost T., Luther M., Chen W., Woychik R.P., Wilkison W.O., Cone R.D. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 371:1994;799-802.
14. Mark A.L., Shaffer R.A., Correia M.L.G., Morgan D.A., Sigmund C.D., Haynes W.G. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J. Hypertens. 17:1999;1949-1953.
15. Matsukawa K., Ninomiya I. Anesthetic effects on tonic and reflex renal sympathetic nerve activity in awake cats. Am. J. Physiol. 256:1989;R371-R378.
16. Matsumura K., Abe I., Tsuchihashi T., Tominaga M., Kobayashi K., Fujishima M. Central effect of endothelin on neurohormonal responses in conscious rabbits. Hypertension. 17:1991;1192-1196.
17. Matsumura K., Tsuchihashi T., Abe I. Central cardiovascular action of neuropeptide Y in conscious rabbits. Hypertension. 36:2000;1040-1044.
18. Matsumura K., Tsuchihashi T., Abe I. Central orexin-A augments sympathoadrenal outflow in conscious rabbits. Hypertension. 37:2001;1382-1387.
19. Matsumura K., Tsuchihashi T., Abe I. Central human cocaine- and amphetamine-regulated transcript peptide 55-102 increases arterial pressure in conscious rabbits. Hypertension. 38:2001;1096-1100.
20. May C.N., Ham I.W., Heslop K.E., Stone F.A., Mathias C.J. Intravenous morphine causes hypertension, hyperglycaemia and increases sympatho-adrenal outflow in conscious rabbits. Clin. Sci. 75:1988;71-77.
21. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8:1994;1298-1308.
22. Rosenfeld R.D., Zeni L., Welcher A.A., Narhi L.O., Hale C., Marasco J., Delaney J., Gleason T., Philo J.S., Katta V., Hui J., Baumgartner J., Graham M., Stark K.L., Karbon W. Biochemical, biophysical, and pharmacological characterization of bacterially expressed human agouti-related protein. Biochemistry. 37:1998;16041-16052.
23. Schwartz M.W., Baskin D.G., Kaiyala K.J., Woods S.C. Model for the regulation of energy balance and adiposity by the central nervous system. Am. J. Clin. Nutr. 69:1999;584-596.
24. Versteeg D.H.G., Florijn W.J., Holtmaat A.J.G.D., Gispen W.H., De Wildt D.J. Synchronism of pressor response and grooming behavior in freely moving, conscious rats following intracerebroventricular administration of ACTH/MSH-like peptides. Brain Res. 631:1993;265-269.